Diamond Hill Capital Management Inc. purchased a new stake in Solventum Co. (NYSE:SOLV - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 240,891 shares of the company's stock, valued at approximately $15,913,000. Diamond Hill Capital Management Inc. owned 0.14% of Solventum as of its most recent filing with the SEC.
Other institutional investors have also recently added to or reduced their stakes in the company. Modus Advisors LLC acquired a new stake in Solventum during the 4th quarter worth $25,000. Stonebridge Financial Group LLC acquired a new stake in Solventum during the 4th quarter worth $26,000. True Wealth Design LLC boosted its stake in Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company's stock worth $33,000 after purchasing an additional 471 shares during the last quarter. Crews Bank & Trust acquired a new stake in Solventum during the 4th quarter worth $32,000. Finally, Prospera Private Wealth LLC acquired a new stake in Solventum during the 3rd quarter worth $35,000.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the stock. Wells Fargo & Company lifted their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a research note on Friday, February 28th. Morgan Stanley lifted their target price on shares of Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 5th. Bank of America lifted their price target on Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a report on Wednesday, February 26th. The Goldman Sachs Group lifted their price target on Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a report on Monday, March 3rd. Finally, Mizuho lifted their price target on Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $79.86.
Read Our Latest Report on Solventum
Solventum Trading Up 1.4 %
SOLV traded up $1.06 on Wednesday, hitting $76.36. The company had a trading volume of 879,693 shares, compared to its average volume of 1,426,054. The firm has a market cap of $13.21 billion and a P/E ratio of 27.77. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $85.92. The company's fifty day moving average price is $74.77 and its 200 day moving average price is $71.38. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.
About Solventum
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Featured Articles
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
